DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

LinksSchließen

Referenz

Di Leo A, Bleiberg H, Buyse M.
Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer. 
J Clin Oncol 2003; 21: 2045-2047  

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in:
Aufrufen in: